Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
J Biol Chem ; 294(31): 11853-11862, 2019 08 02.
Article in English | MEDLINE | ID: mdl-31201272

ABSTRACT

Sodium taurocholate cotransporting polypeptide (NTCP, encoded by Slc10a1/SLC10A1) deficiency can result in hypercholanemia but no obvious symptoms in both mice and humans. However, the consequence of and response to long-term hypercholanemia caused by NTCP deficiency remain largely unexplored. Here, we analyzed lifelong dynamics of serum total bile acid (TBA) levels in Slc10a1-/- mice, and we also assessed changes of TBA levels in 33 young individuals with SLC10A1 loss-of-function variant p.Ser267Phe. We found that overall serum TBA levels tended to decrease gradually with age in both Slc10a1-/- mice and p.Ser267Phe individuals. Liver mRNA profiling revealed notable transcription alterations in hypercholanemic Slc10a1-/- mice, including inhibition of bile acid (BA) synthesis, enhancement of BA detoxification, and altered BA transport. Members of the sulfotransferase (SULT) family showed the most dramatic increases in livers of hypercholanemic Slc10a1-/- mice, and one of their BA sulfates, taurolithocholic acid 3-sulfate, significantly increased. Importantly, consistent with the mouse studies, comprehensive profiling of 58 BA species in sera of p.Ser267Phe individuals revealed a markedly increased level of BA sulfates. Together, our findings indicate that the enhanced BA sulfation is a major mechanism for BA detoxification and elimination in both mice and humans with Slc10a1/SLC10A1 deficiency.


Subject(s)
Bile Acids and Salts/metabolism , Organic Anion Transporters, Sodium-Dependent/genetics , Symporters/genetics , Taurolithocholic Acid/analogs & derivatives , Animals , Bile Acids and Salts/blood , Chromatography, High Pressure Liquid , Female , Homozygote , Humans , Hypercholesterolemia/pathology , Hypercholesterolemia/veterinary , Liver/metabolism , Male , Mice , Mice, Knockout , Organic Anion Transporters, Sodium-Dependent/deficiency , Symporters/deficiency , Tandem Mass Spectrometry , Taurolithocholic Acid/blood , Taurolithocholic Acid/metabolism , Taurolithocholic Acid/urine
2.
Hepatology ; 14(4 Pt 1): 690-5, 1991 Oct.
Article in English | MEDLINE | ID: mdl-1916672

ABSTRACT

The 3-O-glucuronide of lithocholic acid has been shown to be a potent cholestatic agent in rats. However, even after the onset of lithocholic acid glucuronide-induced cholestasis, little of the administered material was recovered in urine. To determine whether this phenomenon was related to the steroid moiety or the form of conjugation, small doses of radiolabeled lithocholic acid glucuronide, lithocholic acid, taurolithocholic acid and/or lithocholic acid sulfate were administered to rats with ligated bile ducts. Urinary excretion of isotope was followed for 24 hr and urinary metabolites of the administered compounds were identified by thin-layer chromatography. Lithocholic and taurolithocholic acids were slowly but relatively efficiently excreted in urine with 73% and 91% of the dose, respectively, recovered in urine over 24 hr. More than 80% of the label in urine from animals receiving these two compounds was in the form of taurine-conjugated beta-muricholic acid. In contrast, lithocholic acid 3-glucuronide and 3-sulfate were poorly excreted: 9% and 12% of the administered doses, respectively, were recovered in urine in 24 hr. Of the small amount of label in urine from rats given the glucuronide, 90% was identified as lithocholic and taurolithocholic acid glucuronides. When lithocholic acid sulfate was given, thin-layer chromatography of urine showed two peaks, which were tentatively identified as tauromurideoxycholic and taurolithocholic acid sulfates. More definitive identification was not possible because of the small amount of the administered dose excreted in urine in these forms.(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Bile Ducts/physiology , Lithocholic Acid/urine , Animals , Chromatography, Thin Layer , Glucuronates/urine , Ligation , Lithocholic Acid/analogs & derivatives , Male , Rats , Rats, Inbred Strains , Taurolithocholic Acid/urine
3.
J Steroid Biochem ; 29(1): 33-9, 1988 Jan.
Article in English | MEDLINE | ID: mdl-2831434

ABSTRACT

From mouse fecal material we have isolated four strictly anaerobic bacteria which, when associated with germfree mice or rats, reduced the cecal volume by 80 and 60%, respectively. This cecal volume-reducing flora did not metabolize estrone-3-sulfate, taurolithocholate-3-sulfate or taurolithocholate but gnotobiotic rats associated with this particular flora (CRF-rats) excreted these compounds faster in feces plus urine than did germfree rats. The time needed for 50% excretion (t1/2) of orally administered estrone-3-sulfate was 32 h in germfree rats versus 13 h in CRF rats; for intraperitoneally injected taurolithocholate-3-sulfate the t1/2 was 63 h in germfree versus 17 h in CRF rats and for taurolithocholate the t1/2 was 199 h in germfree and 96 h in CRF rats. Association of germfree rats with the cecal volume-reducing flora did not change the cecal absorption rate of estrone-3-sulfate, but shortened the 50% small intestinal transit time of [14C]PEG from 10 to 3 h; a value also found in conventional rats. These results stress the important influence of the intestinal microflora on the absorption and excretion of steroids via its effect on the physiology of the whole intestinal tract and point to the deficiencies inherent to the use of germfree animals in excretion studies.


Subject(s)
Cecum/microbiology , Enterohepatic Circulation , Estrone/analogs & derivatives , Intestinal Absorption , Lithocholic Acid/analogs & derivatives , Taurolithocholic Acid/pharmacokinetics , Animals , Cecum/metabolism , Cecum/physiology , Estrogens, Conjugated (USP)/pharmacokinetics , Estrogens, Conjugated (USP)/urine , Estrone/pharmacokinetics , Estrone/urine , Feces/analysis , Feces/microbiology , Female , Gastrointestinal Transit , Male , Rats , Rats, Inbred F344 , Taurolithocholic Acid/urine
4.
Scand J Gastroenterol ; 15(1): 73-80, 1980.
Article in English | MEDLINE | ID: mdl-7367826

ABSTRACT

Urinary bile acid excretion and liver morphology were compared in 25 patients with cystic fibrosis (CF). None showed clinical signs of liver disease. Most of the patients had normal liver function tests. Bile acids were determined in 24-h samples by a modification of the method of Almé. All patients had increased urinary excretion of trihydroxy bile acids, mainly cholic, 3 beta, 7 beta, 12 alpha- and 3 alpha, 7 beta, 12 alpha-trihydroxy-5 beta-cholanoic acids. Lithocholic acid excretion was lower in CF than in normal children. The urinary excretion of 3 beta-hydroxy-5-cholenoic acid was not increased in CF. In three patients with cirrhosis the urinary excretion of chenodeoxycholic acid was increased. The ratio of cholic to 3 beta-hydroxy-5-cholenoic acids was increased in all but three patients, and the ratio of chenodeoxycholic to 3 beta-hydroxy-5-cholenoic acids was increased in those with cirrhosis. These ratios differed more between cirrhotic and non-cirrhotic CF patients in this series than the ratio of cholic to chenodeoxycholic acids.


Subject(s)
Bile Acids and Salts/urine , Cystic Fibrosis/pathology , Liver/pathology , Adolescent , Adult , Child , Child, Preschool , Cholic Acids/urine , Cystic Fibrosis/complications , Cystic Fibrosis/urine , Deoxycholic Acid/urine , Fatty Liver/etiology , Humans , Infant , Lithocholic Acid/urine , Liver Cirrhosis/etiology , Liver Cirrhosis/pathology , Liver Cirrhosis/urine , Liver Function Tests , Taurolithocholic Acid/urine
SELECTION OF CITATIONS
SEARCH DETAIL
...